This inventor holds 3 USPTO granted patents and 5 published patent applications, plus 2 CIPO patents. Top assignee: British Columbia Cancer Agency Branch. Active years: 2015-2022.
Company Filing History:
Years Active: 2015-2022
Title: Marco A Marra: Innovator in Non-Hodgkin Lymphoma Research
Introduction
Marco A Marra is a prominent inventor based in Vancouver, Canada. He has made significant contributions to the field of oncology, particularly in the research and identification of biomarkers for non-Hodgkin lymphomas. With a total of 3 patents to his name, Marra's work is pivotal in advancing the understanding and treatment of this type of cancer.
Latest Patents
One of Marra's latest patents focuses on biomarkers for non-Hodgkin lymphomas and their uses. The disclosure provides a method for identifying a subject as having B-cell non-Hodgkin lymphoma (NHL) by testing a sample for mutations in specific biomarkers. Additionally, the patent describes methods for classifying or monitoring subjects who have, or are suspected of having, B-cell non-Hodgkin lymphoma through similar testing procedures.
Career Highlights
Marco A Marra is associated with the British Columbia Cancer Agency Branch, where he conducts his research and develops innovative solutions for cancer diagnosis and treatment. His work has been instrumental in enhancing the accuracy of lymphoma identification, which is crucial for effective patient management.
Collaborations
Marra collaborates with notable colleagues in his field, including Ryan D Morin and Randy D Gascoyne. These partnerships foster a collaborative environment that enhances research outcomes and drives innovation in cancer treatment.
Conclusion
Marco A Marra's contributions to the field of oncology, particularly in the area of non-Hodgkin lymphoma, highlight his role as a key innovator. His patents and collaborative efforts continue to pave the way for advancements in cancer research and treatment.